Trial intelligence / Profile preview

Initial antifungal treatment regimens for non-HIV cryptococcal meningitis

ChiCTR2000035472Phase 4Not yet recruiting

Sponsor
Huashan Hospital
Start
Aug 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of amphotericin b, fluconazole and flucytosine in cryptococcal meningitis (3 arms), sponsored by Huashan Hospital. Primary endpoint: Adverse drug reaction. Planned start Aug 2020; status: not yet recruiting.

02

Drugs

amphotericin bfluconazoleflucytosine
03

Conditions

cryptococcal meningitis

Beyond the preview

Go deeper on ChiCTR2000035472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call